Dược Lực Học :
BA058, a proprietary analog of human parathyroid hormone-related protein, or hPTHrP, is currently in Phase II development by the company for the treatment of osteoporosis in postmenopausal women. PTHrP is a critical peptide for promoting new bone formation, with a distinct role from parathyroid hormone, or PTH, which primarily regulates calcium homeostasis and bone resorption.
Chỉ Định :
Investigated for use/treatment in osteoporosis.